Inhibition of KLHL21 prevents cholangiocarcinoma progression through regulating cell proliferation and motility, arresting cell cycle and reducing Erk activation - PubMed (original) (raw)
. 2018 May 15;499(3):433-440.
doi: 10.1016/j.bbrc.2018.03.152. Epub 2018 Mar 31.
Affiliations
- PMID: 29574153
- DOI: 10.1016/j.bbrc.2018.03.152
Inhibition of KLHL21 prevents cholangiocarcinoma progression through regulating cell proliferation and motility, arresting cell cycle and reducing Erk activation
Jian Chen et al. Biochem Biophys Res Commun. 2018.
Abstract
Kelch-like family member 21 (KLHL21) is involved in cell mitosis and motility. Nevertheless, the clinical significance and biological function of KLHL21 in cholangiocarcinoma (CCA) are elusive. This is the first study to describe a pivotal role for KLHL21 in the progression of CCA. The expression of KLHL21 was elevated in CCA tissues compared with paired normal bile duct tissues. In addition, immunohistochemical and statistical analyses demonstrated that the expression of KLHL21 correlated inversely with tumor histological grade (p < 0.05) and the overall survival of patients (p < 0.01). In CCA cells, we found that the inhibition of KLHL21 significantly reduced proliferation, migration and invasion. Further results indicated that inhibition of KLHL21 triggered G0/G1 cell cycle arrest, leading to the increased expression of P21 and P27 and decreased expression of Cyclin E1, which eventually resulted in proliferation suppression in CCA cells. Furthermore, KLHL21 knockdown alleviated the activation of the Erk signaling pathway via decreasing the expression of phospho-Erk1/2. Our data demonstrated that KLHL21 plays an essential role in the tumorigenesis and progression of CCA, implying that it might serve as a potential therapeutic target for CCA treatment.
Keywords: Cell cycle; Cholangiocarcinoma; KLHL21; Motility; Proliferation.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
- Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
Zhang H, Li Z, Chu B, Zhang F, Zhang Y, Ke F, Chen Y, Xu Y, Liu S, Zhao S, Liang H, Weng M, Wu X, Li M, Wu W, Quan Z, Liu Y, Zhang Y, Gong W. Zhang H, et al. Tumour Biol. 2016 Jun;37(6):8305-15. doi: 10.1007/s13277-015-4704-4. Epub 2016 Jan 4. Tumour Biol. 2016. PMID: 26729195 - Sprouty4 correlates with favorable prognosis in perihilar cholangiocarcinoma by blocking the FGFR-ERK signaling pathway and arresting the cell cycle.
Qiu B, Chen T, Sun R, Liu Z, Zhang X, Li Z, Xu Y, Zhang Z. Qiu B, et al. EBioMedicine. 2019 Dec;50:166-177. doi: 10.1016/j.ebiom.2019.11.021. Epub 2019 Nov 22. EBioMedicine. 2019. PMID: 31761616 Free PMC article. - Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
Zheng T, Hong X, Wang J, Pei T, Liang Y, Yin D, Song R, Song X, Lu Z, Qi S, Liu J, Sun B, Xie C, Pan S, Li Y, Luo X, Li S, Fang X, Bhatta N, Jiang H, Liu L. Zheng T, et al. Hepatology. 2014 Mar;59(3):935-46. doi: 10.1002/hep.26705. Epub 2014 Jan 29. Hepatology. 2014. PMID: 24037855 - Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker.
Chiang KC, Yeh TS, Wu RC, Pang JS, Cheng CT, Wang SY, Juang HH, Yeh CN. Chiang KC, et al. Sci Rep. 2016 Oct 26;6:36138. doi: 10.1038/srep36138. Sci Rep. 2016. PMID: 27782193 Free PMC article. - Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition.
Xu Y, Yao Y, Qin W, Zhong X, Jiang X, Cui Y. Xu Y, et al. Biomed Pharmacother. 2018 Mar;99:121-127. doi: 10.1016/j.biopha.2018.01.061. Epub 2018 Jan 10. Biomed Pharmacother. 2018. PMID: 29329034
Cited by
- miR-181-5p/KLHL5 Promoted Proliferation and Migration of Gastric Cancer Through Activating METTL3-Mediated m6A Process.
Li R, Li Y, Wang Z, Suo R, Ma R, Zhang J. Li R, et al. Mol Biotechnol. 2024 Sep;66(9):2415-2425. doi: 10.1007/s12033-023-00877-x. Epub 2023 Sep 21. Mol Biotechnol. 2024. PMID: 37733183 - Kelch-like proteins in the gastrointestinal tumors.
Fu AB, Xiang SF, He QJ, Ying MD. Fu AB, et al. Acta Pharmacol Sin. 2023 May;44(5):931-939. doi: 10.1038/s41401-022-01007-0. Epub 2022 Oct 20. Acta Pharmacol Sin. 2023. PMID: 36266566 Free PMC article. Review. - Cullin 3 Exon 9 Deletion in Familial Hyperkalemic Hypertension Impairs Cullin3-Ring-E3 Ligase (CRL3) Dynamic Regulation and Cycling.
Kouranti I, Abdel Khalek W, Mazurkiewicz S, Loisel-Ferreira I, Gautreau AM, Pintard L, Jeunemaitre X, Clauser E. Kouranti I, et al. Int J Mol Sci. 2022 May 5;23(9):5151. doi: 10.3390/ijms23095151. Int J Mol Sci. 2022. PMID: 35563538 Free PMC article. - Tumor-promoting mechanisms of macrophage-derived extracellular vesicles-enclosed microRNA-660 in breast cancer progression.
Li C, Li R, Hu X, Zhou G, Jiang G. Li C, et al. Breast Cancer Res Treat. 2022 Apr;192(2):353-368. doi: 10.1007/s10549-021-06433-y. Epub 2022 Jan 27. Breast Cancer Res Treat. 2022. PMID: 35084622 - The _Cis_-Regulatory Code for Kelch-like 21/30 Specific Expression in Ciona robusta Sensory Organs.
Coppola U, Kamal AK, Stolfi A, Ristoratore F. Coppola U, et al. Front Cell Dev Biol. 2020 Sep 11;8:569601. doi: 10.3389/fcell.2020.569601. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33043001 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous